Authorisation requise
Investigating anti-D in an individual with the weak D type 2 genotype
, , , , , et
22 sept. 2022
À propos de cet article
Publié en ligne: 22 sept. 2022
Pages: 77 - 81
DOI: https://doi.org/10.21307/immunohematology-2022-046
Mots clés
© 2022 S. Phou et al., published by Sciendo
Phou, S.
Transfusion Medicine, Cedars-Sinai Medical Center, Department of Pathology and Laboratory MedicineLos Angeles, United States
Nguyen, N.
Immunohematology Reference Laboratory, American Red CrossPomona, United States
Revilla, J.
Immunohematology Reference Laboratory, American Red CrossPomona, United States
Rodberg, K.
Immunohematology Reference Laboratory, American Red CrossPomona, United States
Gibb, D.R.
Transfusion Medicine, Cedars-Sinai Medical Center, Department of Pathology and Laboratory MedicineLos Angeles, United States
Pepkowitz, S.H.
Transfusion Medicine, Cedars-Sinai Medical Center, Department of Pathology and Laboratory MedicineLos Angeles, United States
Klapper, E.B.
Transfusion Medicine, Cedars-Sinai Medical Center, Department of Pathology and Laboratory MedicineLos Angeles, United States